ORCHARD THERAPEUTICS NORTH AMERICA

Lobbying client · Massachusetts · filed 2025 to 2025

Biopharmaceutical company.

$50,000 Reported spend

2 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page is grouped by the client's LDA id (59564), not by name.

Firms hired 1

LMH STRATEGIC SOLUTIONS $50,000 2 filings

Bills named in these filings 2

HR 1509
Accelerating Kids’ Access to Care Act of 2025

2 filings
S 752
Accelerating Kids’ Access to Care Act

2 filings

Reported by year 1 year

2025 $50,000 2 filings

Issues lobbied 1

Health Issues 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 2 total

2T

LMH STRATEGIC SOLUTIONS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $20,000 income · posted Jul 15, 2025

View → Q1

LMH STRATEGIC SOLUTIONS

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $30,000 income · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.